|
Re: Heavier than normal trading on the OTC for RVXCF
|
5
|
Resverlogix Corp.
|
Mar 15, 2017 08:46PM
|
|
Re: Heavier than normal trading on the OTC for RVXCF
|
5
|
Resverlogix Corp.
|
Mar 16, 2017 10:53AM
|
|
Re: Heavier than normal trading on the OTC for RVXCF
|
2
|
Resverlogix Corp.
|
Mar 16, 2017 12:15PM
|
|
Re: Heavier than normal trading on the OTC for RVXCF
|
3
|
Resverlogix Corp.
|
Mar 16, 2017 03:55PM
|
|
Re: Heavier than normal trading on the OTC for RVXCF
|
3
|
Resverlogix Corp.
|
Mar 15, 2017 04:38PM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
3
|
Resverlogix Corp.
|
Apr 12, 2021 07:00PM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
4
|
Resverlogix Corp.
|
Apr 12, 2021 07:08PM
|
|
Re: Heading for a big volume day?
|
1
|
Resverlogix Corp.
|
Jun 05, 2018 01:06PM
|
|
Re: HDL Functionality
|
2
|
Resverlogix Corp.
|
May 08, 2019 04:36PM
|
|
Re: HDL Functionality
|
1
|
Resverlogix Corp.
|
May 08, 2019 05:25PM
|
|
Re: HDL Functionality
|
8
|
Resverlogix Corp.
|
May 06, 2019 05:50PM
|
|
Re: HDL Functionality
|
1
|
Resverlogix Corp.
|
May 09, 2019 04:44PM
|
|
Re: HDL Functionality
|
1
|
Resverlogix Corp.
|
May 09, 2019 06:34PM
|
|
Re: HDL from an Alzheimer's disease perspective
|
4
|
Resverlogix Corp.
|
Jun 27, 2019 04:24PM
|
|
Re: Hate to say it here first
|
1
|
Resverlogix Corp.
|
Sep 29, 2019 11:01PM
|
|
Re: Hate to say it here first
|
|
Resverlogix Corp.
|
Sep 29, 2019 11:03PM
|
|
Re: Hate to say it here first
|
|
Resverlogix Corp.
|
Sep 29, 2019 11:08PM
|
|
Re: Has Kenneth Lebioda done presentations before?
|
4
|
Resverlogix Corp.
|
Sep 22, 2017 01:32AM
|
|
Re: Happy Turkey Day to all the Americans here....
|
8
|
Resverlogix Corp.
|
Nov 28, 2019 12:36AM
|
|
Re: Happy Thanksgiving all....
|
4
|
Resverlogix Corp.
|
Oct 15, 2019 04:22PM
|
